January 13th, 2020
Muscular dystrophy collaboration aims to correct muscle stem cells’ DNA
Harvard stem cell research, currently in mice, receives support from Sarepta to advance in-vivo genome editing toward prospective therapy
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
January 8th, 2020
R&D alliance between Harvard and Deerfield announces first project agreement
Lab1636 commits to advance certain Harvard innovations toward a possible therapeutic for tactile hypersensitivity experienced in autism spectrum disorders
January 6th, 2020
December 2019 patents
Innovations in targeting genome editors, synthesizing cortistatin analogues, systems to modulate cardiac rhythm using light, microfluidic devices, and more
December 9th, 2019
November 2019 patents
Innovations in 3D printing, targeted genome editing, soft robotics, systems for culturing cells, tactile sensors, and more
December 6th, 2019
Empowering mucosal healing with an engineered probiotic
Genetically programmed, living hydrogel material facilitates intestinal wound healing and may lead to a therapy for patients with inflammatory bowel disease
